Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next-generation-sequencing-based testing for _NTRK_ gene fusions. He presents the case of a patient who benefited from precision medicine based on the detection of an _NTRK1_ fusion by comprehensive genomic profiling. Dr. Subbiah is the medical director of the Clinical Center for Targeted Therapy and executive director of Oncology Research at the University of Texas MD Anderson Cancer Network. Listen to the podcast episode to learn more about when to test for _NTRK_ fusions: /science/genomics-podcast/testing-for-ntrk-fusions.html Learn about Homologous Recombination Deficiency (HRD) testing in ovarian cancer: https://youtu.be/54yI7Sxvnfc The VR真人彩票 Oncology series is brought to you by Medical Affairs. M-GL-01113 Subscribe to the VR真人彩票 video channel http://www.youtube.com/subscription_center?add_user=VR真人彩票Inc A global genomics leader, VR真人彩票 provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. VR真人彩票 technology is responsible for generating more than 90% of the world鈥檚 sequencing data.* Through collaborative innovation, VR真人彩票 is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. VR真人彩票., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View VR真人彩票 webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View VR真人彩票 product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View VR真人彩票 support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illumina Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina